DeborahJLevineMD

Pulmonology • Stanford, CA

Critical Care Medicine, Lung Transplantation Medicine, Pleural Disease, Pulmonary Vascular Medicine

Professor, Medicine, University of Texas Medical School, San Antonio Medical Director Lung Transplantation Director of Pulmonary Hypertension Center

Join to view full profile

Dr. Levine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Levine's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Fax+1 210-450-6018

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2003
University of Arizona College of MedicineClass of 1996

Certifications & Licensure

CA State Medical License 2022 - 2026
AZ State Medical License 1999 - 2024
TX State Medical License 2005 - 2023
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

1 citations
Transplantation, bridging, and support technologies in pulmonary hypertension.
Laurent Savale, Alberto Benazzo, Paul Corris, Shaf Keshavjee, Deborah Jo Levine
The European Respiratory Journal. 2024-10-01
1 citations
Triazole antifungal drug interactions-practical considerations for excellent prescribing.
Russell Lewis, Saarah Niazi-Ali, Andrew McIvor, Souha S Kanj, Johan Maertens
The Journal of Antimicrobial Chemotherapy. 2024-06-03
2 citations
The 2022 Banff Meeting Lung Report.
Elizabeth N Pavlisko, Benjamin A Adam, Gerald J Berry, Fiorella Calabrese, Nahir Cortes-Santiago
American Journal of Transplantation. 2024-04-01

Journal Articles

Banff Lung Report: Current Knowledge and Future Research Perspectives for Diagnosis and Treatment of Pulmonary Antibody Mediated Rejection (AMR)
Deborah Levine, MD, American journal of transplantation

Press Mentions

TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business UpdateAugust 12th, 2021
Health: Women Experience 'Significantly Faster' Declines in Cognition Than MenFebruary 26th, 2021
‘We’re Poised to Do It’: University Hospital to Perform Double Lung Transplants for COVID-19 Patients with Irreversible Lung DamageOctober 23rd, 2020